VEON LTD ($VEON) is expected to release its quarterly earnings data on Thursday, November 13th before market open, per Finnhub. Analysts are expecting revenue of $1,114,860,000 and earnings of -$2.25 per share.
You can see Quiver Quantitative's $VEON stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
VEON LTD Hedge Fund Activity
We have seen 41 institutional investors add shares of VEON LTD stock to their portfolio, and 31 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HELIKON INVESTMENTS LTD removed 949,357 shares (-64.9%) from their portfolio in Q3 2025, for an estimated $51,673,501
- MORGAN STANLEY added 249,213 shares (+62.6%) to their portfolio in Q2 2025, for an estimated $11,481,242
- TWO SIGMA INVESTMENTS, LP added 191,932 shares (+1046.5%) to their portfolio in Q2 2025, for an estimated $8,842,307
- DIAMETER CAPITAL PARTNERS LP removed 164,186 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $7,564,049
- CIBC WORLD MARKET INC. removed 120,270 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $5,540,838
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND added 75,200 shares (+inf%) to their portfolio in Q2 2025, for an estimated $3,464,464
- LINGOTTO INVESTMENT MANAGEMENT LLP added 70,659 shares (+1.2%) to their portfolio in Q2 2025, for an estimated $3,255,260
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
VEON LTD Analyst Ratings
Wall Street analysts have issued reports on $VEON in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Benchmark issued a "Buy" rating on 06/16/2025
To track analyst ratings and price targets for VEON LTD, check out Quiver Quantitative's $VEON forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
